Yu Yi, Liang Hong-Feng, Chen Jing, Li Zhi-Bin, Han Yu-Shuai, Chen Jia-Xi, Li Ji-Cheng
Central Laboratory, Yangjiang People's Hospital, Yangjiang, China.
Center for Analyses and Measurements, College of Chemical Engineering, Zhejiang University of Technology, Hangzhou, China.
Front Psychiatry. 2021 Jun 11;12:620371. doi: 10.3389/fpsyt.2021.620371. eCollection 2021.
Postpartum depression (PPD) is a serious health issue that can affect about 15% of the female population within after giving birth. It often conveys significant negative consequences to the offsprings. The symptoms and risk factors are somewhat similar to those found in non-postpartum depression. The main difference resides in the fact that PPD is triggered by postpartum specific factors, including especially biological changes in the hormone levels. Patients are usually diagnosed using a questionnaire onsite or in a clinic. Treatment of PPD often involves psychotherapy and antidepressant medications. In recent years, there have been more researches on the identification of biological markers for PPD. In this review, we will focus on the current research status of PPD, with an emphasis on the recent progress made on the identification of PPD biomarkers.
产后抑郁症（PPD）是一个严重的健康问题，大约15%的女性在产后会受到影响。它通常会给后代带来重大的负面后果。其症状和风险因素与非产后抑郁症有一定相似之处。主要区别在于PPD是由产后特定因素引发的，尤其是激素水平的生物学变化。患者通常通过现场或诊所的问卷调查来诊断。PPD的治疗通常包括心理治疗和抗抑郁药物。近年来，关于PPD生物标志物识别的研究越来越多。在这篇综述中，我们将关注PPD的当前研究现状，重点是PPD生物标志物识别方面的最新进展。
